AC Immune (ACIU) Change in Cash (2015 - 2025)

AC Immune (ACIU) has 11 years of Change in Cash data on file, last reported at -$958396.1 in Q4 2025.

• Change in Cash for Q4 2025 came in at -$958396.1, down 143.93% year-over-year; the trailing twelve-month figure through Dec 2025 was $36.5 million (up 147.43% YoY), and the FY2025 annual result was -$8.1 million, up 82.45% from the prior year.
• Change in Cash slipped to -$958396.1 in Q4 2025 per ACIU's latest filing, from $45.6 million in the prior quarter.
• Over five years, Change in Cash peaked at $54.2 million in Q4 2023 and troughed at -$51.2 million in Q2 2021.
• A 5-year average of -$6.4 million and a median of -$11.6 million in 2021 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2021 and 2023: Change in Cash tumbled 1408.62% in 2021, then jumped 514.78% in 2023.
• A 5-year view of Change in Cash shows it stood at -$11.7 million in 2021, then declined by 11.48% to -$13.1 million in 2022, then jumped by 514.78% to $54.2 million in 2023, then slumped by 95.98% to $2.2 million in 2024, then plunged by 143.93% to -$958396.1 in 2025.
• Business Quant data shows ACIU's Change in Cash at -$958396.1 in Q4 2025, $45.6 million in Q3 2025, and $9.7 million in Q2 2025.